Market Currents
More on Edwards Life Sciences (EW): Q4 beats on EPS but misses on revenue, due in large part to...
-
Thursday, February 2, 2012, 4:37 PM ETMore on Edwards Life Sciences (EW): Q4 beats on EPS but misses on revenue, due in large part to the late approval of Sapien, its catheter-delivered heart valve. The device gained FDA approval in late November and saw only marginal sales impact during the quarter. Shares -4.3% AH.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
